Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence|SAMHSA

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid DependenceSAMHSA

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

.

ELECTRONIC ONLY

Advisory - ELECTRONIC ONLY

Download Digital Version

• SMA12-4682.pdf (PDF, 655 KB)

Very poor Not that bad Average Good Perfect

Do NOT fill in this textbox:

Price: FREE (shipping charges may apply)

Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.